ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis-Reference-Cited by-同舟云学术

ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis

Published:2021-09-29 Issue:2 Volume:29 Page:945-946
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kubo Masahiko,Kobayashi Shogo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10865-7.pdf

Reference5 articles.

1. Yamamoto T, Sugiura T, Mizuno T, Okamura Y, Aramaki T, Endo M, et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22(2):677–84.

2. Song BI, Kim HW, Won KS, Ryu SW, Sohn SS, Kang YN. Preoperative standardized uptake value of metastatic lymph nodes measured by 18F-FDG PET/CT improves the prediction of prognosis in gastric cancer. Medicine (Baltimore). 2015;94(26):e1037.

3. Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, et al. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol. 2011;103(3):223–9.

4. Kubo M, Kobayashi S, Gotoh K, Takayama H, Iwagami Y, Yamada D, et al. Preoperative FDG positive lymph nodes predict the postoperative prognosis in resectable biliary tract cancers. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10820-6

5. Sakai D, Kanai M, Kobayashi S, Eguchi H, Baba H, Seo S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA). Ann Oncol . 2018;29(Suppl):8.